Sandstrom Anne, Errico Kristen, Roy Debanshu, Carpenter Andrea J, Prasad Anand
Department of Cardiothoracic Surgery, UT Health San Antonio, San Antonio, Texas, USA.
Department of Medicine, Divison of Cardiology, UT Health San Antonio, San Antonio, Texas, USA.
Case Rep Cardiol. 2025 Jun 7;2025:3481920. doi: 10.1155/cric/3481920. eCollection 2025.
Mechanical circulatory support devices, such as the Impella catheter (Abiomed, Danvers, Massachusetts), continue to become more commonplace in patients undergoing high-risk percutaneous coronary intervention (PCI) or those in cardiogenic shock. Thrombus in the left ventricle is a contraindication to Impella placement. Here, we present a patient with an anterior ST elevation myocardial infarction who underwent primary PCI with subsequent development of cardiogenic shock followed by Impella placement, who then later developed an LV thrombus. The Impella was removed after placement of a Sentinel cerebral protection device (Boston Scientific, Massachusetts). The left carotid filter of the Sentinel captured a thrombus fragment. The patient did not have any neurological compromise. This case represents the first report of actual capture of LV thrombus by a Sentinel system in this context. The case suggests the potential value of the Sentinel cerebral protection device to lower the risk of an embolic event during Impella removal in selective clinical scenarios.
机械循环支持设备,如Impella导管(美国马萨诸塞州丹弗斯市的Abiomed公司生产),在接受高风险经皮冠状动脉介入治疗(PCI)的患者或心源性休克患者中越来越常见。左心室血栓是Impella置入的禁忌症。在此,我们报告一例前壁ST段抬高型心肌梗死患者,该患者接受了直接PCI,随后发生心源性休克并置入了Impella,之后又出现了左心室血栓。在置入Sentinel脑保护装置(美国马萨诸塞州的波士顿科学公司生产)后移除了Impella。Sentinel的左颈动脉过滤器捕获了一个血栓碎片。患者没有任何神经功能损害。该病例是在此背景下Sentinel系统实际捕获左心室血栓的首例报告。该病例提示,在选择性临床情况下,Sentinel脑保护装置在降低Impella移除过程中发生栓塞事件风险方面具有潜在价值。